These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2178127)

  • 21. Characterization of EIAV immunogenicity during persistent infections: humoral responses and antigen targets.
    Montelaro RC; Ball JM; Issel CJ
    Dev Biol Stand; 1990; 72():19-30. PubMed ID: 1704323
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.
    Perryman LE; O'Rourke KI; McGuire TC
    J Virol; 1988 Aug; 62(8):3073-6. PubMed ID: 2839723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.
    Soutullo A; García MI; Bailat A; Racca A; Tonarelli G; Malan Borel I
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):335-43. PubMed ID: 16105689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus.
    Banks KL; Henson JB; McGuire TC
    Lab Invest; 1972 Jun; 26(6):701-7. PubMed ID: 4337973
    [No Abstract]   [Full Text] [Related]  

  • 25. The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.
    Lin YZ; Cao XZ; Li L; Li L; Jiang CG; Wang XF; Ma J; Zhou JH
    Virus Res; 2011 Sep; 160(1-2):274-82. PubMed ID: 21782860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
    Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
    Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection of bone marrow macrophages by equine infectious anemia virus.
    Swardson CJ; Lichtenstein DL; Wang S; Montelaro RC; Kociba GJ
    Am J Vet Res; 1997 Dec; 58(12):1402-7. PubMed ID: 9401688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of a cell membrane antigen by equine infectious anemia virus.
    McGuire TC; Crawford TB
    Am J Vet Res; 1978 Mar; 39(3):385-6. PubMed ID: 205145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of equine infectious anemia virus in horse leukocyte cultures derived from horses in various stages of equine infectious anemia viral infection.
    Evans KS; Carpenter SL; Sevoian M
    Am J Vet Res; 1984 Jan; 45(1):20-5. PubMed ID: 6322623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of hemagglutinating antigen of equine infectious anemia virus from infected equine leukocyte cultures.
    Sentsui H; Kono Y
    Natl Inst Anim Health Q (Tokyo); 1978; 18(1):39-40. PubMed ID: 206841
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional.
    Russell KE; Perkins PC; Hoffman MR; Miller RT; Walker KM; Fuller FJ; Sellon DC
    Virology; 1999 Jun; 259(1):7-19. PubMed ID: 10364485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.
    Mealey RH; Fraser DG; Oaks JL; Cantor GH; McGuire TC
    Clin Immunol; 2001 Nov; 101(2):237-47. PubMed ID: 11683583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
    Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
    Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.
    Craigo JK; Sturgeon TJ; Cook SJ; Issel CJ; Leroux C; Montelaro RC
    Virology; 2006 Jan; 344(2):340-53. PubMed ID: 16226288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of a CFSE-based flow cytometry for evaluating EIAV-stimulated proliferation of T lymphocytes].
    Lin YZ; Deng XL; Shen N; Lü XL; Zhao LP; Kong XG; Shao YM; Zhou JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1044-7. PubMed ID: 18992187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic response to EIAV offers hope for AIDS treatment.
    Kahler S
    J Am Vet Med Assoc; 1992 Dec; 201(11):1672-3. PubMed ID: 1338067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.